AR
Advisory Research Portfolio holdings
AUM
$651M
1-Year Return
25.02%
This Quarter Return
+0.62%
1 Year Return
+25.02%
3 Year Return
+143.09%
5 Year Return
+422.22%
10 Year Return
+498.78%
AUM
$720M
AUM Growth
-$59.6M
(-7.6%)
Cap. Flow
-$29.1M
Cap. Flow
% of AUM
-4.04%
Top 10 Holdings %
Top 10 Hldgs %
17.21%
Holding
510
New
74
Increased
122
Reduced
203
Closed
86
Top Buys
| 1 |
GSK
GSK
|
$4.17M |
| 2 |
JBTM
JBT Marel Corporation
JBTM
|
$3.67M |
| 3 |
Northern Oil and Gas
NOG
|
$3.52M |
| 4 |
PRSU
Pursuit Attractions and Hospitality, Inc.
PRSU
|
$3.45M |
| 5 |
Fluor
FLR
|
$3.35M |
Top Sells
| 1 |
DEN
Denbury Inc.
DEN
|
$7.65M |
| 2 |
Reliance Steel & Aluminium
RS
|
$5.6M |
| 3 |
CHX
ChampionX
CHX
|
$4.75M |
| 4 |
Accenture
ACN
|
$4.01M |
| 5 |
On Holding
ONON
|
$3.48M |
Sector Composition
| 1 | Technology | 21.41% |
| 2 | Consumer Discretionary | 17.64% |
| 3 | Industrials | 15.62% |
| 4 | Healthcare | 11.67% |
| 5 | Financials | 10.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Cellebrite
CLBT
$4.07B
| $1.69M | 0.23% |
220,335
+150,931
| +217% | +$1.15M |
|
127
Holley
HLLY
$464M
| $1.68M | 0.23% |
336,561
+15,772
| +5% | +$78.7K |
|
128
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$16.3B
| $1.63M | 0.23% |
33,566
| – | – |
|
129
Preformed Line Products
PLPC
$949M
| $1.62M | 0.22% |
9,943
+1,427
| +17% | +$232K |
|
130
Invesco S&P 500 Equal Weight ETF
RSP
$74B
| $1.61M | 0.22% |
11,395
+2
| +0% | +$283 |
|
|
CBAY
131
DELISTED
Cymabay Therapeutics
CBAY
| $1.56M | 0.22% |
104,540
-17,693
| -14% | -$264K |
|
132
iShares MBS ETF
MBB
$41.3B
| $1.56M | 0.22% |
17,518
| – | – |
|
133
First Merchants
FRME
$2.37B
| $1.55M | 0.21% |
55,640
-195
| -0.3% | -$5.43K |
|
134
C3.ai
AI
$2.14B
| $1.53M | 0.21% |
60,106
+10,446
| +21% | +$267K |
|
135
Ares Capital
ARCC
$15.8B
| $1.53M | 0.21% |
78,377
-1,231
| -2% | -$24K |
|
136
Noble Corp
NE
$4.54B
| $1.52M | 0.21% |
30,079
+11,990
| +66% | +$607K |
|
137
Trinity Industries
TRN
$2.31B
| $1.52M | 0.21% |
62,437
-2,110
| -3% | -$51.4K |
|
138
Oracle
ORCL
$655B
| $1.52M | 0.21% |
14,330
-135
| -0.9% | -$14.3K |
|
139
LegalZoom.com
LZ
$1.87B
| $1.52M | 0.21% |
138,628
-156,280
| -53% | -$1.71M |
|
140
Tesla
TSLA
$1.13T
| $1.5M | 0.21% |
6,005
-2,316
| -28% | -$580K |
|
141
McDonald's
MCD
$224B
| $1.48M | 0.2% |
5,600
-66
| -1% | -$17.4K |
|
142
Union Pacific
UNP
$131B
| $1.44M | 0.2% |
7,090
-231
| -3% | -$47K |
|
143
Bank of America
BAC
$368B
| $1.43M | 0.2% |
52,335
-2,343
| -4% | -$64.2K |
|
144
Kirby Corp
KEX
$4.99B
| $1.41M | 0.2% |
+16,990
| New | +$1.41M |
|
145
Abbott
ABT
$231B
| $1.4M | 0.19% |
14,425
+821
| +6% | +$79.5K |
|
146
Exact Sciences
EXAS
$10.2B
| $1.39M | 0.19% |
20,311
-5,742
| -22% | -$392K |
|
147
Regal Rexnord
RRX
$9.66B
| $1.38M | 0.19% |
9,644
+1,071
| +12% | +$153K |
|
148
Evolent Health
EVH
$1.11B
| $1.37M | 0.19% |
50,354
-13,517
| -21% | -$368K |
|
|
ROVR
149
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
| $1.37M | 0.19% |
218,674
-77,419
| -26% | -$485K |
|
150
Vermilion Energy
VET
$1.12B
| $1.37M | 0.19% |
93,525
-10,333
| -10% | -$151K |
|